SCHEMBL10281158

SCHEMBL10281158

CC(C)N1C(=O)CCC(N2C(=O)c3ccccc3C2=O)C1=O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 15/20 0.50
DDB1 Q16531 14/20 0.50
IKZF3 Q9UKT9 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CHRM2 P08172 1/20 0.50
OPRM1 P35372 1/20 0.50
CYP1A2 P05177 1/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TNF P01375 1/20 0.39
IL1B P01584 1/20 0.39
TBXA2R P21731 1/20 0.39
IKZF1 Q13422 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10281239 0.86 DDB1 (0.56) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL19370783 0.81 DDB1 (0.47) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL19359312 0.81 DDB1 (0.60) CRBNDDB1IKZF3ALDH1A1TDP1
SCHEMBL19370784 0.80 DDB1 (0.46) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL845548 0.80 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL26510118 0.80 CRBN (0.54) CRBNSMN1; SMN2CYP2D6
SCHEMBL27861226 0.79 CRBN (0.42) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL27843749 0.79 CRBN (0.41) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL13364982 0.77 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL13271120 0.77 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346955-A1 COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF APRINOIA THERAPEUTICS LIMITED (CN) 2023-11-02 US disclosed
US-11642413-B2 Compounds for degrading Tau protein aggregates and uses thereof APRINOIA THERAPEUTICS LIMITED (CN) 2023-05-09 US disclosed
US-20180194732-A1 MULTI-API LOADING PRODRUGS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-07-12 US disclosed
US-20180194732-A1 MULTI-API LOADING PRODRUGS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-07-12 US disclosed
US-20160024011-A1 Multi-API Loading Prodrugs ALKERMES PHARMA IRELAND LTD (IE) 2016-01-28 US disclosed
US-20120202823-A1 Multi-API Loading Prodrugs ALKERMES, INC. 2012-08-09 US disclosed
US-20120202823-A1 Multi-API Loading Prodrugs ALKERMES, INC. 2012-08-09 US disclosed
WO-2012088441-A1 MULTI- API LOADING PRODRUGS ALKERMES, INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024011-A1 Multi-API Loading Prodrugs AADAC, PAICS, ABCG2 CRBN 3484/4885DDB1 3767/4885IKZF3 1386/4885
US-20230346955-A1 COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF MAPT, PRNP, APP CRBN 1080/4885DDB1 1918/4885IKZF3 4742/4885
US-20120202823-A1 Multi-API Loading Prodrugs AADAC, PAICS, ABCG2 CRBN 3484/4885DDB1 3767/4885IKZF3 1386/4885
US-11642413-B2 Compounds for degrading Tau protein aggregates and uses thereof MAPT, PRNP, APP CRBN 1080/4885DDB1 1918/4885IKZF3 4742/4885
US-20180194732-A1 MULTI-API LOADING PRODRUGS AADAC, PAICS, ABCG2 CRBN 3484/4885DDB1 3767/4885IKZF3 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.